Advance Online
Advance Online

Answers to COVID-19 Vaccine Questions

NPF task force co-chair, Dr. Joel Gelfand, M.D., answers your questions on COVID-19 vaccines.

On December 12, 2020, the National Psoriasis Foundation (NPF) COVID-19 Task Force released updated guidance regarding COVID-19 and psoriatic disease, including new guidance statements on vaccine use for people with psoriasis and/or psoriatic arthritis.

Since that time, NPF has heard many questions from members of our community. We complied questions commonly asked of NPF leadership and staff with questions posed by community members on NPF social media channels and through the Patient Navigation Center to create this brief Q and A video with NPF COVID-19 Task Force co-chair, Dr. Joel Gelfand, M.D., of the University of Pennsylvania Perelman School of Medicine.

Hear Dr. Joel Gelfand, M.D., answer your COVID-19 vaccine questions.

Looking for More on COVID-19?

Visit the NPF COVID-19 Resource Center for the stories, guidance and information you need as we navigate this pandemic together.

Learn more about COVID-19

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2021 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.